Researcher - Dr Andrew Chantry
Institution - University of East Anglia
Grant award - £89,334.00
Reference - S13-007
PhD student - Jessica Watt
We want to develop new drugs to block a destructive protein called WWP2 found inside prostate cancer cells and so stop it from attacking our natural defences against prostate cancer growth.
There are often many side-effects and long-term complications associated with current treatments for prostate cancer. WWP2 is a protein involved in sending and receiving messages inside the cell. Dr Chantry’s earlier research has shown that if the amount of WWP2 increases it can cause tumour cells to become more aggressive. This project will look at new ways to block WWP2 and confirm whether this could be a good drug target for new prostate cancer treatments.